Skip to main content
. 2020 Sep 28;13:3301–3308. doi: 10.2147/IDR.S247524

Table 3.

Summary of Mutations Reported by the Abbott RT MTBRIF/INH Assay

Drug Mutation Information n %
Rif Total 51 100%
PB4- 18 35.3%
PB2- 11 21.6%
PB5- 11 21.6%
PB7- 6 11.8%
PB2-, PB5- 3 5.9%
PB6- 1 1.9%
Mutation not listed 1 1.9%
INH Total 43 100%
katG inhA
315T1 33 76.7%
−15T 7 16.3%
315T1 −15T 1 2.3%
MUT 1 2.3%
MUT 1 2.3%